Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-04

Clinical Trial Update: ET-blockade and Exercise Induced Blood Flow in T2DM [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating endothelin blockade and exercise-induced blood flow in Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Endothelin receptor blocker

Snippet

Sponsor: Radboud University Medical Center | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED